Planta Med 2007; 73(2): 184-187
DOI: 10.1055/s-2006-957081
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Petasiphenone, a Phenol Isolated from Cimicifuga Racemosa, in vitro Inhibits Proliferation of the Human Prostate Cancer Cell Line LNCaP

Hubertus Jarry1 , Stefan Stromeier2 , Wolfgang Wuttke1 , Adolf Nahrstedt2
  • 1Division of Clinical and Experimental Endocrinology, University of Göttingen, Göttingen, Germany
  • 2Institute of Pharmaceutical Biology and Phytochemistry, University of Münster, Münster, Germany
Further Information

Publication History

Received: August 28, 2006

Accepted: December 5, 2006

Publication Date:
13 February 2007 (online)

Abstract

Extracts of Cimicifuga racemosa (L.) Nutt. (syn.: Actaea racemosa L.) (CR) inhibit the proliferation of the human prostate cancer cell line LNCaP. Recently, the phenylpropanoid ester 3,4-dihydroxyphenacyl caffeate (petasiphenone, 1) was isolated from CR. This substance is a structural homologue to petasiphenol ([3-(3,4-dihydroxyphenyl)-2-oxopropyl caffeate]), a compound produced by Petasites japonicus Sieb. & Zucc. which inhibits the growth of various human leukemia cell lines. Because of the structural similarity, we examined whether 1 affects the proliferation of LNCaP cells and the secretion of prostate-specific antigen (PSA). Under basal conditions as well as under co-incubation with 10 nM estradiol [E2 or 1 nM dihydrotestosterone (DHT)], 1 dose-dependently inhibited proliferation of LNCaP cells while PSA release per cell was not altered. We report for the first time that a defined compound isolated from CR inhibits the growth of the human prostate cancer cells LNCaP.

References

  • 1 Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18.  Anticancer Res. 2005;  25 139-47
  • 2 Jarry H, Thelen P, Christoffel V, Spengler B, Wuttke W. Cimicifuga racemosa extract BNO 1055 inhibits proliferation of the human prostate cancer cell line LNCaP.  Phytomedicine. 2005;  12 178-82
  • 3 Stromeier S, Petereit F, Nahrstedt A. Phenolic esters from the rhizomes of Cimicifuga racemosa do not cause proliferation effects in MCF-7 cells.  Planta Med. 2005;  71 495-500
  • 4 Mizushina Y, Hirota M, Murakami C, Ishidoh T, Kamisuki S, Shimazaki N. et al . Some anti-chronic inflammatory compounds are DNA polymerase lambda-specific inhibitors.  Biochem Pharmacol. 2003;  66 1935-44
  • 5 Matsubara K, Mori M, Mizushina Y. Petasiphenol which inhibits DNA polymerase lambda activity is an inhibitor of in vitro angiogenesis.  Oncol Rep. 2004;  11 447-51
  • 6 Mizushina Y, Kamisuki S, Kasai N, Ishidoh T, Shimazaki N, Takemura M. et al . Petasiphenol: a DNA polymerase lambda inhibitor.  Biochemistry. 2002;  41 14 463-71
  • 7 Culig Z, Klocker H, Bartsch G, Hobisch A. Androgen receptors in prostate cancer.  Endocr Relat Cancer. 2002;  9 155-70
  • 8 Arnold J T, Le H, McFann K K, Blackman M R. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.  Am J Physiol Endocrinol Metab. 2005;  288 E573-84
  • 9 Jana N R, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C, Sone H. Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells.  Biochem Biophys Res Commun. 1999;  256 462-8

Prof. Dr. Hubertus Jarry

Division of Clinical and Experimental Endocrinology

Department of Obstetrics and Gynaecology

University of Göttingen

Robert Koch-Strasse 40

37075 Göttingen

Germany

Phone: +49-551-396-522

Fax: +49-551-396-518

Email: hubjarry@med.uni-goettingen.de

>